Data from recent clinical trials of high-versus moderate-dose statin therapy support the
recommendation to achieve a low-density lipoprotein (LDL)< 100 mg/dl in high-risk patients …

Objective: To systematically review and analyse evidence for cholesterol-lowering efficacy of
at least 4 weeks of add-on ezetimibe vs doubling statin dose, in adults with primary …

The third edition of this well-received text provides a state-of-the-art treatise on modern
clinical practice relating to hyperlipidaemia and lipoprotein disorders, conditions responsible …

Objective: To review and analyse the evidence for the cholesterol-lowering effect of
ezetimibe in adult patients with hypercholesterolaemia who are not at low-density …

OBJECTIVE To compare the efficacy and safety of the recommended usual starting and next
highest doses of ezetimibe/simvastatin and atorvastatin in patients with type 2 diabetes …

Objective: To assess the lipid-altering efficacy and safety of ezetimibe/simvastatin single
tablet product compared with rosuvastatin at the approved usual starting, next highest, and …

Background: Statin treatment may be associated with adverse effects on glucose
metabolism. Whether this is a class effect is not known. In contrast, ezetimibe monotherapy …

Background Despite lipid-lowering and antiplatelet therapy, the pattern of residual
lipoproteins seems relevant to long-term cardiovascular outcomes. This study aims to …

This review considers the hypolipidaemic drugs that act on the gastrointestinal (GI) tract. We
searched PubMed up to April 2008 and included randomized controlled trials, original …

Ezetimibe represents a new lipid lowering agent which inhibits cholesterol absorption. It
effectively reduces low-density lipoprotein cholesterol when administered either alone or in …